Caribou Biosciences (CRBU) Change in Acquisitions & Divestments (2022 - 2026)

Caribou Biosciences (CRBU) has reported Change in Acquisitions & Divestments for 5 consecutive years, with $46.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 30.04% year-over-year to $46.1 million; the TTM figure through Mar 2026 stood at $233.0 million (down 36.4% YoY), while the FY2025 annual figure was $252.8 million, down 36.39% from the prior year.
• Change in Acquisitions & Divestments slipped to $46.1 million in Q1 2026 per CRBU's latest filing, from $61.8 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $120.7 million in Q3 2024 and bottomed at $39.3 million in Q1 2022.
• Historically, Change in Acquisitions & Divestments has averaged $75.7 million across 5 years, with a median of $68.4 million in 2025.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments jumped 151.06% — and 2025, when it sank 47.43%.
• Caribou Biosciences' Change in Acquisitions & Divestments stood at $89.7 million in 2022, then plunged by 38.72% to $55.0 million in 2023, then soared by 30.81% to $71.9 million in 2024, then dropped by 14.11% to $61.8 million in 2025, then declined by 25.32% to $46.1 million in 2026.
• Business Quant data shows CRBU's Change in Acquisitions & Divestments at $46.1 million in Q1 2026, $61.8 million in Q4 2025, and $68.4 million in Q3 2025.